Open AccessPrognostic Value of a T-Cell–Based, Interferon-γ Biomarker in Children with Tuberculosis Contact
Author(s) -
Mustafa Bakır,
Kerry Millington,
Ahmet Soysal,
Jonathan J Deeks,
Serpil Efee,
Yasemin Aslan,
Davinder Dosanjh,
Ajit Lalvani
Publication year - 2008
Publication title -
annals of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.839
H-Index - 390
eISSN - 1539-3704
pISSN - 0003-4819
DOI - 10.7326/0003-4819-149-11-200812020-00248
Subject(s) - elispot , medicine , tuberculosis , tuberculin , incidence (geometry) , immunology , tuberculosis diagnosis , active tuberculosis , latent tuberculosis , contact tracing , mycobacterium tuberculosis , antigen , pathology , disease , physics , optics , covid-19 , infectious disease (medical specialty) , cd8
Enzyme-linked immunospot (ELISpot) assay is an increasingly widely used, T-cell-based, interferon-gamma-release assay for diagnosing tuberculosis infection, but whether positive results are prognostic of active tuberculosis is not known.